Derm Topics

Pain Management After Dermatologic Surgery Cheat Sheet
postoperative painDermatologic surgery (particularly Mohs micrographic surgery) is associated with low overall postoperative pain that is largely readily resolvable with acetaminophen and ibuprofen. However, certain medical history and predisposing factors for postoperative pain (discussed below) may present scenarios where a broader repertoire of analgesics is required. In this Surgical Dermatology Cheat Sheet, we …
postoperative pain
The Many Faces of Post-Inflammatory Hyperpigmentation (PIH)
Our new series, “The Many Faces of”, showcases side-by-side images of some of the most commonly seen dermatology conditions in an array of skin tones and briefly highlight nuances in clinical presentation.  All images featured in the series are part of The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas, a resource developed by co-editors Misty Eleryan, MD, MS, and Adam Friedman, …
Skin Eruption – Friday Pop Quiz 7/15
A 7-year-old girl presents with a swollen earlobe for several days treated by her pediatrician with oral antihistamines and topical mupirocin. The eruption progresses to that shown in the image in addition to the development of fever, malaise, and neck pain. What would be the next best step in management for this patient? A. Obtain a bacterial culture B. Increase dosage and frequency of …
Lipedema: What Every Dermatologist Needs to Know
lipedemaNext Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference, interviewed Dr. C. William Hanke (who currently serves as Program Director for the Micrographic Surgery/Dermatologic Oncology Fellowship Training Program at Ascension St. Vincent Hospital in Indianapolis) about Lipedema. Watch him define the 3 stages of this chronic medical condition, so dermatologists can …
lipedema
Journal Buzz: Botulinum Toxin for Hidradenitis Suppurativa | The Expert Weighs In
botulinum toxinBotulinum toxin is a safe and potentially effective treatment alternative in hidradenitis suppurativa (HS) patients who are resistant to standard therapies, according to the authors of a systematic review published in the Journal of Drugs in Dermatology. How does this review add to the conversation about new treatments for HS? In which HS patients might dermatologists consider botulinum toxin as …
botulinum toxin